Meridian Bioscience reported $6.66M in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2100M 911M
Atrion ATRI:US 8.28M 647K
Becton, Dickinson and BDX:US $ 265M 260M
Bio Rad Laboratories BIO:US $ 3928.03M 3013.92M
Cerulean Pharma CERU:US $ -12.67M 3.5M
Cerus CERS:US $ -12.44M 2.92M
Genmark Diagnostics GNMK:US $ -3.72M 0.5M
Luminex LMNX:US $ 9.08M 8.84M
Meridian Bioscience VIVO:US $ 6.66M 5.01M
Myriad Genetics MYGN:US $ 24.6M 29.3M
Neogen NEOG:US $ 17.08M 1.32M
Orasure Technologies OSUR:US $ -15.02M 13.65M
Oxford Immunotec Global OXFD:US $ -0.15M 9.54M
Quidel QDEL:US $ 215.75M 196.68M
Rockwell Medical RMTI:US $ -7.58M 0.82M
Sientra SIEN:US $ 28.41M 48.54M
Staar Surgical STAA:US $ 6.02M 2.55M
Thermo Fisher Scientific TMO:US $ 1902M 74M
Trinity Biotech TRIB:US $ -0.78M 2.38M